These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 31085700)
1. Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non-Small Cell Lung Cancer. Song M; Ping Y; Zhang K; Yang L; Li F; Zhang C; Cheng S; Yue D; Maimela NR; Qu J; Liu S; Sun T; Li Z; Xia J; Zhang B; Wang L; Zhang Y Cancer Res; 2019 Jul; 79(14):3737-3748. PubMed ID: 31085700 [TBL] [Abstract][Full Text] [Related]
2. IL-10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF-κB/Notch1 pathway in non-small cell lung cancer. Yang L; Dong Y; Li Y; Wang D; Liu S; Wang D; Gao Q; Ji S; Chen X; Lei Q; Jiang W; Wang L; Zhang B; Yu JJ; Zhang Y Int J Cancer; 2019 Aug; 145(4):1099-1110. PubMed ID: 30671927 [TBL] [Abstract][Full Text] [Related]
3. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway. Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493 [TBL] [Abstract][Full Text] [Related]
4. Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma. Hao C; Liu G; Tian G Ther Adv Respir Dis; 2019; 13():1753466619866097. PubMed ID: 31368411 [TBL] [Abstract][Full Text] [Related]
5. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo. Zhou B; Wang D; Sun G; Mei F; Cui Y; Xu H Cell Physiol Biochem; 2018; 46(3):999-1008. PubMed ID: 29669316 [TBL] [Abstract][Full Text] [Related]
6. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer. Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952 [TBL] [Abstract][Full Text] [Related]
7. JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1. Wang Q; Wu J; Wei H; Huang H; Huang Y; Fang H; Gong X; Sun J; Wu Y; Lei C; Yu J; Hu D Int J Biochem Cell Biol; 2021 Sep; 138():106040. PubMed ID: 34246759 [TBL] [Abstract][Full Text] [Related]
8. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas. Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668 [TBL] [Abstract][Full Text] [Related]
9. Small Molecule Inhibition of MERTK Is Efficacious in Non-Small Cell Lung Cancer Models Independent of Driver Oncogene Status. Cummings CT; Zhang W; Davies KD; Kirkpatrick GD; Zhang D; DeRyckere D; Wang X; Frye SV; Earp HS; Graham DK Mol Cancer Ther; 2015 Sep; 14(9):2014-22. PubMed ID: 26162689 [TBL] [Abstract][Full Text] [Related]
10. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer. Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356 [TBL] [Abstract][Full Text] [Related]
11. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner. Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089 [TBL] [Abstract][Full Text] [Related]
12. Anthricin‑induced caspase‑dependent apoptosis through IGF1R/PI3K/AKT pathway inhibition in A549 human non‑small lung cancer cells. Park BR; Lee SA; Moon SM; Kim CS Oncol Rep; 2018 Jun; 39(6):2769-2776. PubMed ID: 29620219 [TBL] [Abstract][Full Text] [Related]
13. Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities. Hung WY; Chang JH; Cheng Y; Chen CK; Chen JQ; Hua KT; Cheng CW; Hsiao M; Chung CL; Lee WJ; Chien MH Cell Physiol Biochem; 2018; 51(1):337-355. PubMed ID: 30453282 [TBL] [Abstract][Full Text] [Related]
14. Vertebral-specific activation of the CX3CL1/ICAM-1 signaling network mediates non-small-cell lung cancer spinal metastasis by engaging tumor cell-vertebral bone marrow endothelial cell interactions. Wang K; Jiang L; Hu A; Sun C; Zhou L; Huang Y; Chen Q; Dong J; Zhou X; Zhang F Theranostics; 2021; 11(10):4770-4789. PubMed ID: 33754027 [No Abstract] [Full Text] [Related]
15. EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer. Cheng CC; Chou KF; Wu CW; Su NW; Peng CL; Su YW; Chang J; Ho AS; Lin HC; Chen CG; Yang BL; Chang YC; Chiang YW; Lim KH; Chang YF Lung Cancer; 2018 Feb; 116():80-89. PubMed ID: 29413056 [TBL] [Abstract][Full Text] [Related]
16. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties. Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activity of Shikonin against afatinib resistant non-small cell lung cancer via negative regulation of PI3K/Akt signaling pathway. Li B; Yuan Z; Jiang J; Rao Y Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30420490 [TBL] [Abstract][Full Text] [Related]
18. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1. Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500 [TBL] [Abstract][Full Text] [Related]
19. Icariin induces apoptosis of human lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway. Wu X; Kong W; Qi X; Wang S; Chen Y; Zhao Z; Wang W; Lin X; Lai J; Yu Z; Lai G Life Sci; 2019 Dec; 239():116879. PubMed ID: 31682849 [TBL] [Abstract][Full Text] [Related]
20. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling. Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]